Crossmark

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer

Crossref DOI link: https://doi.org/10.1186/s13014-018-1147-2

Published Online: 2018-10-23

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thureau, Sébastien

Dubray, Bernard

Modzelewski, Romain

Bohn, Pierre

Hapdey, Sébastien

Vincent, Sabine

Anger, Elodie

Gensanne, David

Pirault, Nicolas

Pierrick, Gouel

Vera, Pierre
License Information

Text and Data Mining valid from 2018-10-23
More Information

Article History

Received: 14 August 2018

Accepted: 3 October 2018

First Online: 23 October 2018

Ethics approval and consent to participate

: All data were extracted from one prospective study (NCT01576796). For all patients, we are a consent.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.